Published in J Rheumatol on November 01, 2000
Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther (2009) 3.47
Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis. Arthritis Res Ther (2010) 1.48
Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis. Ann Rheum Dis (2003) 1.22
Osteoporosis in inflammatory joint diseases. Osteoporos Int (2010) 1.21
The skeleton in rheumatoid arthritis: common mechanisms for bone erosion and osteoporosis? J Rheumatol (2000) 1.07
Prevalence of vertebral fractures in patients with rheumatoid arthritis: revisiting the role of glucocorticoids. Osteoporos Int (2011) 1.04
Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation. Arthritis Res Ther (2005) 1.02
Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis. Ann Rheum Dis (2007) 1.01
A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass. Arthritis Res Ther (2010) 0.98
Advances in the medical treatment of rheumatoid arthritis. Hand Clin (2011) 0.93
Development and validation of the osteoporosis prescreening risk assessment (OPERA) tool to facilitate identification of women likely to have low bone density. Clin Rheumatol (2004) 0.93
A comparison of three different guidelines for osteoporosis treatment in patients with rheumatoid arthritis in Korea. Korean J Intern Med (2010) 0.92
Significance of risk factors for osteoporosis is dependent on gender and menopause in rheumatoid arthritis. Rheumatol Int (2008) 0.91
Bone quality and bone mass as assessed by quantitative ultrasound and dual energy x ray absorptiometry in women with rheumatoid arthritis: relationship with quadriceps strength. Ann Rheum Dis (2002) 0.90
Risk factors associated with the occurrence of hip fracture in Japanese patients with rheumatoid arthritis: a prospective observational cohort study. Osteoporos Int (2012) 0.90
Fracture risk assessment and osteoporosis treatment disparities in 3,970 Japanese patients with rheumatoid arthritis. Clin Rheumatol (2011) 0.90
[Prophylaxis and treatment of osteoporosis in patients with rheumatoid arthritis (ORA study)]. Z Rheumatol (2011) 0.86
Bone mineral density in patients with early rheumatoid arthritis treated with corticosteroids. Clin Rheumatol (2004) 0.85
Long-term anti-arthritic and anti-osteoporotic effects of raloxifene in established experimental postmenopausal polyarthritis. Clin Exp Immunol (2008) 0.84
Effects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in rheumatoid arthritis: a population-based cohort study. J Bone Miner Res (2012) 0.83
Predictors of osteoporosis screening completion rates in a primary care practice. Popul Health Manag (2011) 0.82
Risk factors associated with incident fractures in Japanese men with rheumatoid arthritis: a prospective observational cohort study. J Bone Miner Metab (2008) 0.82
Bone mineral density changes in patients with recent-onset rheumatoid arthritis. Clin Med Insights Arthritis Musculoskelet Disord (2011) 0.82
Combined treatment with dexamethasone and raloxifene totally abrogates osteoporosis and joint destruction in experimental postmenopausal arthritis. Arthritis Res Ther (2011) 0.82
Vertebral fractures affect functional status in postmenopausal rheumatoid arthritis patients. J Bone Miner Metab (2013) 0.82
Effects of oestradiol and raloxifene on the induction and effector phases of experimental postmenopausal arthritis and secondary osteoporosis. Clin Exp Immunol (2011) 0.81
Role of endogenous and exogenous female sex hormones in arthritis and osteoporosis development in B10.Q-ncf1*/* mice with collagen-induced chronic arthritis. BMC Musculoskelet Disord (2010) 0.81
Physical activity prevents bone loss in premenopausal women with rheumatoid arthritis: a cohort study. Rheumatol Int (2008) 0.81
Prevalence of vertebral fractures in a disease activity steered cohort of patients with early active rheumatoid arthritis. BMC Musculoskelet Disord (2012) 0.81
The influence of vertebral fracture on the functional disability of patients with rheumatoid arthritis. J Korean Med Sci (2014) 0.81
[Diagnosis and treatment of osteoporosis and rheumatoid arthritis in accordance with German guidelines. Results of a survey of patients, primary care physicians and rheumatologists]. Z Rheumatol (2011) 0.81
Outcome of balloon kyphoplasty for the treatment of osteoporotic vertebral compression fracture in patients with rheumatoid arthritis. BMC Musculoskelet Disord (2016) 0.80
Bone mineral density and frequency of osteoporosis among Vietnamese women with early rheumatoid arthritis. Clin Rheumatol (2011) 0.80
Bone and TNF in rheumatoid arthritis: clinical implications. RMD Open (2015) 0.79
The effect of low-dose methotrexate on bone mineral density in patients with early rheumatoid arthritis. Rheumatol Int (2003) 0.78
The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis. BMC Musculoskelet Disord (2016) 0.78
Height Restoration after Balloon Kyphoplasty in Rheumatoid Patients with Osteoporotic Vertebral Compression Fracture. Asian Spine J (2015) 0.77
Hormone replacement therapy, calcium and vitamin D3 versus calcium and vitamin D3 alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456]. Arthritis Res Ther (2004) 0.77
Bone ultrasonography in glucocorticoid-induced osteoporosis. Osteoporos Int (2004) 0.76
The addition of tocilizumab to DMARD therapy for rheumatoid arthritis: a meta-analysis of randomized controlled trials. Eur J Clin Pharmacol (2009) 0.76
The risk of osteoporotic fractures according to the FRAX model in Korean patients with rheumatoid arthritis. J Korean Med Sci (2014) 0.76
Selective oestrogen receptor modulators lasofoxifene and bazedoxifene inhibit joint inflammation and osteoporosis in ovariectomised mice with collagen-induced arthritis. Rheumatology (Oxford) (2015) 0.76
Body composition in patients with rheumatoid arthritis is not different than healthy subjects. Eur J Rheumatol (2014) 0.75
Self-reported disability in adults with severe obesity. J Obes (2011) 0.75
Whole body bone tissue and cardiovascular risk in rheumatoid arthritis. J Osteoporos (2014) 0.75
Dual X-Ray Absorptiometry Whole Body Composition of Bone Tissue in Rheumatoid Arthritis - a Cross-Sectional Study. Maedica (Buchar) (2015) 0.75
Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis. Osteoporos Int (2016) 0.75
Prevalence and risk factors associated with low-impact fractures in men with rheumatoid arthritis. Clin Rheumatol (2013) 0.75
Skeletal complications of rheumatoid arthritis. Osteoporos Int (2017) 0.75
Relationship between bone mineral density and urine level of NTx in rheumatoid arthritis. J Bone Miner Metab (2005) 0.75
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes (2001) 9.67
Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med (2001) 9.57
Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med (1998) 8.56
Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med (1999) 5.65
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab (2005) 3.67
Metformin in non-alcoholic steatohepatitis. Lancet (2001) 3.63
Alendronate for the treatment of osteoporosis in men. N Engl J Med (2000) 3.11
Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int (2006) 2.79
Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet (1997) 2.78
Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology (2001) 2.74
Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol (1998) 2.70
The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis. J Bone Miner Res (2003) 2.50
Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups. JAMA (1997) 2.46
Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology (1997) 2.21
The time course of a hypercalcaemic crisis in acute primary hyperparathyroidism. Lancet (1984) 2.21
Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest (2001) 2.10
Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nat Immunol (2000) 2.01
Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur J Immunol (1994) 2.01
R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney Int (2007) 2.01
Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study. Am J Med (1996) 1.99
Presence of antibodies against Helicobacter pylori and its heat-shock protein 60 in the serum of patients with Sjögren's syndrome. J Rheumatol (1999) 1.89
The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int (2009) 1.85
Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. J Clin Invest (1996) 1.83
Quantitative heel ultrasound in a population-based study in Italy and its relationship with fracture history: the ESOPO study. Osteoporos Int (2005) 1.80
Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study. J Bone Miner Res (2000) 1.80
Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. J Clin Endocrinol Metab (2013) 1.77
Strontium absorption and excretion in normocalciuric subjects: relation to calcium metabolism. Clin Chem (1998) 1.76
Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data. Osteoporos Int (2008) 1.76
High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care (2001) 1.74
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study. Ann Rheum Dis (2005) 1.66
Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group. Aging (Milano) (2000) 1.59
Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. Kidney Int (2001) 1.58
Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer (1996) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Indwelling ureteral stents and sexual health: a prospective, multivariate analysis. J Urol (2007) 1.55
Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity. J Immunol (2001) 1.55
Assessing 5-year incidence rates and determinants of osteoporotic fractures in primary care. Bone (2011) 1.55
Incidence and costs of hip fractures compared to acute myocardial infarction in the Italian population: a 4-year survey. Osteoporos Int (2006) 1.54
Elective segmental ureterectomy for transitional cell carcinoma of the ureter: long-term follow-up in a series of 73 patients. BJU Int (2012) 1.51
Treatment of an aneurysm of the coeliac axis by transluminal steel wire occlusion. Eur J Vasc Endovasc Surg (1997) 1.48
Blood pressure changes produced by kidney cross-transplantation between spontaneously hypertensive rats and normotensive rats. Clin Sci Mol Med (1974) 1.47
Ultrasonography in ulnar neuropathy at the elbow: relationships to clinical and electrophysiological findings. Neurophysiol Clin (2008) 1.46
CSF T-cell subsets in multiple sclerosis: relationship to cerebrospinal fluid myelin basic protein and clinical activity. J Neurol (1989) 1.46
Noninvasive management of obstructing ureteral stones using electromagnetic extracorporeal shock wave lithotripsy. Surg Endosc (2008) 1.46
Physiological carotid body denervation during aging. Adv Exp Med Biol (2009) 1.45
Bone loss in response to long-term glucocorticoid therapy. Bone Miner (1990) 1.44
High prevalence of thyroid autoantibodies in newly diagnosed rheumatoid arthritis patients. Clin Exp Rheumatol (2003) 1.43
Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist. J Clin Endocrinol Metab (1999) 1.43
The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. Blood (1998) 1.42
Tolerability of risedronate in postmenopausal women intolerant of alendronate. Aging (Milano) (2001) 1.40
Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int (2003) 1.36
Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int (2011) 1.33
Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens (2001) 1.30
Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension. Hypertension (1999) 1.28
Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int (2008) 1.26
Myopathy as the persistently isolated symptomatology of primary autoimmune hypothyroidism. Thyroid (1998) 1.25
Osteoporosis in young adults: pathophysiology, diagnosis, and management. Osteoporos Int (2012) 1.25
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis. J Bone Miner Res (2002) 1.22
Tumor seeding in urological laparoscopy: an international survey. J Urol (2004) 1.21
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 1.19
Bone fragility in men--where are we? Osteoporos Int (2006) 1.19
Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: a long-term survey of ovarian cancer patients. J Neurol (1997) 1.18
Toxicity due to remission inducing drugs in rheumatoid arthritis. Association with HLA-B35 and Cw4 antigens. J Rheumatol (1986) 1.17
Morphine tissue levels and reduction of gastrointestinal transit in rats. Correlation supports primary action site in the gut. Gastroenterology (1983) 1.16
The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs. Br J Pharmacol (1981) 1.15
Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites. J Pharmacol Exp Ther (1986) 1.15
A knotted multi-length ureteral stent: a rare complication. Urol Res (2004) 1.13
Radioimmunoassay of 1,25-dihydroxy vitamin D2: studies on the metabolism of vitamin D2 in man. Clin Endocrinol (Oxf) (1983) 1.13
Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss. Ciblos Study Group. J Clin Endocrinol Metab (1998) 1.11
Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors. Med Biol Eng Comput (2012) 1.11
Hypertension may be transplanted with the kidney in humans: a long-term historical prospective follow-up of recipients grafted with kidneys coming from donors with or without hypertension in their families. J Am Soc Nephrol (1996) 1.11
Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2012) 1.10
Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays. Hypertension (1997) 1.10
Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. J Clin Endocrinol Metab (1993) 1.09
Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09
Evidence for an interaction between adducin and Na(+)-K(+)-ATPase: relation to genetic hypertension. Am J Physiol (1999) 1.08
Hypomagnesaemia: studies of parathyroid hormone secretion and function. Clin Endocrinol (Oxf) (1984) 1.08
Isozyme-dependent sensitivity of adenylyl cyclases to P-site-mediated inhibition by adenine nucleosides and nucleoside 3'-polyphosphates. J Biol Chem (1997) 1.07
Engagement of the mannose receptor by tumoral mucins activates an immune suppressive phenotype in human tumor-associated macrophages. Clin Dev Immunol (2011) 1.07
Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib. Ann Rheum Dis (2004) 1.06
Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. J Clin Invest (1985) 1.06
Prognostic indicators in compensated cirrhosis. Am J Gastroenterol (1991) 1.06
Galactose elimination capacity and liver volume in aging man. Hepatology (1988) 1.06
IL-2-regulated expression of the monocyte chemotactic protein-1 receptor (CCR2) in human NK cells: characterization of a predominant 3.4-kilobase transcript containing CCR2B and CCR2A sequences. J Immunol (1997) 1.05
Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis (2010) 1.05
Measurement of the Υ1S, Υ2S, and Υ3S polarizations in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2013) 1.05
The course of galactose elimination capacity in patients with alcoholic cirrhosis: possible use as a surrogate marker for death. Hepatology (1996) 1.04
Alpha-adducin polymorphisms and renal sodium handling in essential hypertensive patients. Kidney Int (1998) 1.04
Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO). Osteoporos Int (2007) 1.03
Comparison between a cisplatin-containing regimen and a carboplatin-containing regimen for recurrent or metastatic bladder cancer patients. A randomized phase II study. Cancer (1996) 1.02
Prevalence and correlates of vertebral fractures in adults with cystic fibrosis. Bone (2004) 1.02
Role of metalloproteases in the release of the IL-1 type II decoy receptor. J Biol Chem (1997) 1.02
[Incidence and socioeconomic burden of hip fractures in Italy]. Reumatismo (2005) 1.02
Functional hepatic flow and Doppler-assessed total hepatic flow in control subjects and in patients with cirrhosis. J Hepatol (1995) 1.02
Dichloromethylene-diphosphonate in patients with prostatic carcinoma metastatic to the skeleton. J Urol (1985) 1.02